Three-year outcomes from an ongoing clinical trial suggest that high-dose immunosuppressive therapy followed by the transplantation of a person's own blood-forming stem cells may induce sustained remission in some people with relapsing-remitting multiple sclerosis . RRMS is the most common form of MS, a progressive autoimmune disease in which the immune system attacks the brain and spinal cord.
http://www.pharmscope.com/news/2014-12-30-000000/stem-cell-transplants-may-halt-progression-multiple-sclerosis
http://www.pharmscope.com/news/2014-12-30-000000/stem-cell-transplants-may-halt-progression-multiple-sclerosis
No comments:
Post a Comment